Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyong-Mi Chang

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
JAMA Cardiology|October 1, 2025
Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related CardiomyopathiesDimitri J Maamari, Kiran J Biddinger, Sean J Jurgens, et al.
Open Forum Infectious Diseases|July 24, 2023
Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient VeteransJennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, et al.
American Journal of Human Genetics|August 8, 2025
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunctionHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2020
Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief ReportAeron M Small, Jennifer E Huffman, Derek Klarin, et al.
Scientific Reports|June 3, 2021
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestryMargaret M Parker, Scott M Damrauer, Catherine Tcheandjieu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver DiseaseHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
Hepatology (Baltimore, Md.)|February 12, 2021
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver DiseaseOren K Fix, Emily A Blumberg, Kyong-Mi Chang, et al.
The American Journal of Gastroenterology|August 10, 2005
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infectionEdmund J Bini, Norbert Bräu, Sue Currie, et al.
Antiviral Research|December 18, 2017
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshopTimothy M Block, Harvey Alter, Nathaniel Brown, et al.
Diabetologia|May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysisJames Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
JAMA Cardiology|October 1, 2025
Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related CardiomyopathiesDimitri J Maamari, Kiran J Biddinger, Sean J Jurgens, et al.
Open Forum Infectious Diseases|July 24, 2023
Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient VeteransJennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, et al.
American Journal of Human Genetics|August 8, 2025
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunctionHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2020
Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief ReportAeron M Small, Jennifer E Huffman, Derek Klarin, et al.
Scientific Reports|June 3, 2021
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestryMargaret M Parker, Scott M Damrauer, Catherine Tcheandjieu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver DiseaseHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
Hepatology (Baltimore, Md.)|February 12, 2021
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver DiseaseOren K Fix, Emily A Blumberg, Kyong-Mi Chang, et al.
The American Journal of Gastroenterology|August 10, 2005
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infectionEdmund J Bini, Norbert Bräu, Sue Currie, et al.
Antiviral Research|December 18, 2017
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshopTimothy M Block, Harvey Alter, Nathaniel Brown, et al.
Diabetologia|May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysisJames Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
Pageof 15